{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:20:47Z","timestamp":1791930047939,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100009032","name":"Pfizer UK","doi-asserted-by":"publisher","award":["WI 171046"],"award-info":[{"award-number":["WI 171046"]}],"id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009032","name":"Pfizer UK","doi-asserted-by":"publisher","award":["WI 171046"],"award-info":[{"award-number":["WI 171046"]}],"id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13054-016-1326-1","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T07:20:24Z","timestamp":1462519224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study"],"prefix":"10.1186","volume":"20","author":[{"given":"Maria","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Katchanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Wijaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Christner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azien","family":"Laqmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"issue":"1","key":"1326_CR1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","volume":"183","author":"AH Limper","year":"2011","unstructured":"Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):96\u2013128.","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"1326_CR2","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","volume":"360","author":"BH Segal","year":"2009","unstructured":"Segal BH. Aspergillosis. N Engl J Med. 2009;360(18):1870\u201384.","journal-title":"N Engl J Med"},{"key":"1326_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","volume":"13","author":"JW Baddley","year":"2013","unstructured":"Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M. Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis. 2013;13:29.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1326_CR4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170(6):621\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"1326_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2012.06805.x","volume":"1272","author":"G Dimopoulos","year":"2012","unstructured":"Dimopoulos G, Frantzeskaki F, Poulakou G, Armaganidis A. Invasive aspergillosis in the intensive care unit. Ann NY Acad Sci. 2012;1272:31\u20139.","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"1326_CR6","first-page":"173","volume":"26","author":"J Garnacho-Montero","year":"2013","unstructured":"Garnacho-Montero J, Olaechea P, Alvarez-Lerma F, Alvarez-Rocha L, Blanquer J, Galvan B, et al. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. Rev Esp Quimioter. 2013;26(2):173\u201388.","journal-title":"Rev Esp Quimioter"},{"issue":"4","key":"1326_CR7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30(4):782\u2013800.","journal-title":"Eur Respir J"},{"issue":"s1","key":"1326_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13693780600919262","volume":"44","author":"KH Vandewoude","year":"2006","unstructured":"Vandewoude KH, Vogelaers D, Blot SI. Aspergillosis in the ICU \u2013 the new 21st century problem? Med Mycol. 2006;44(s1):71\u20136.","journal-title":"Med Mycol"},{"issue":"5","key":"1326_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","volume":"59","author":"K Vandewoude","year":"2004","unstructured":"Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg. 2004;59(5):251\u20137.","journal-title":"Acta Clin Belg"},{"issue":"1","key":"1326_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1326_CR11","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","volume":"10","author":"KH Vandewoude","year":"2006","unstructured":"Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care. 2006;10(1):R31.","journal-title":"Crit Care"},{"issue":"5","key":"1326_CR12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","volume":"33","author":"MM McNeil","year":"2001","unstructured":"McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997. Clin Infect Dis. 2001;33(5):641\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1326_CR13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcrc.2006.03.006","volume":"21","author":"F Khasawneh","year":"2006","unstructured":"Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care. 2006;21(4):322\u20137.","journal-title":"J Crit Care"},{"key":"1326_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","volume":"19","author":"FS Taccone","year":"2015","unstructured":"Taccone FS, Van den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015;19:7.","journal-title":"Crit Care"},{"issue":"2","key":"1326_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007;45(2):205\u201316.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1326_CR16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00063-013-0238-y","volume":"109","author":"G Egerer","year":"2014","unstructured":"Egerer G, Schmitt T. Fungal infections in hematology patients and after blood stem cell transplantation: prophylaxis and treatment. Med Klin Intensivmed Notfmed. 2014;109(7):526\u201330.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"12","key":"1326_CR17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"1326_CR18","doi-asserted-by":"crossref","unstructured":"Donnelly P. Trends in medical mycology 2015, Oral presentation, Symposium 14. Scientific Programme. Mycoses 2015;58:3-9.","DOI":"10.1111\/myc.12374"},{"issue":"3","key":"1326_CR19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00134-014-3592-1","volume":"41","author":"M Aliaga","year":"2015","unstructured":"Aliaga M, Forel JM, De Bourmont S, Jung B, Thomas G, Mahul M, et al. Diagnostic yield and safety of CT scans in ICU. Intensive Care Med. 2015;41(3):436\u201343.","journal-title":"Intensive Care Med"},{"key":"1326_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","volume":"13","author":"CO Morrissey","year":"2013","unstructured":"Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis. 2013;13:519\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1326_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008;177(1):27\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1326_CR22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00134-007-0792-y","volume":"33","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Van Wijngaerden E. Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med. 2007;33(10):1679\u201381.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1326_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7182\/pit2013386","volume":"23","author":"G Soeffker","year":"2013","unstructured":"Soeffker G, Wichmann D, Loderstaedt U, Sobottka I, Deuse T, Kluge S. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis. Prog Transplant. 2013;23(1):71\u20134.","journal-title":"Prog Transplant"},{"issue":"3","key":"1326_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/JCM.00750-11","volume":"50","author":"A Bergeron","year":"2012","unstructured":"Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol. 2012;50(3):823\u201330.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1326_CR25","doi-asserted-by":"crossref","first-page":"e90176","DOI":"10.1371\/journal.pone.0090176","volume":"9","author":"LY Chai","year":"2014","unstructured":"Chai LY, Kullberg BJ, Earnest A, Johnson EM, Teerenstra S, Vonk AG, et al. Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis. PLoS One. 2014;9(2):e90176.","journal-title":"PLoS One"},{"issue":"4","key":"1326_CR26","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/cc11443","volume":"16","author":"H He","year":"2012","unstructured":"He H, Ding L, Sun B, Li F, Zhan Q. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study. Crit Care. 2012;16(4):R138.","journal-title":"Crit Care"},{"issue":"1","key":"1326_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1164\/rccm.201204-0761ED","volume":"186","author":"E Azoulay","year":"2012","unstructured":"Azoulay E, Afessa B. Diagnostic criteria for invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):8\u201310.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-016-1326-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:34:38Z","timestamp":1567838078000},"score":1,"resource":{"primary":{"URL":"http:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-016-1326-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1186\/s13054-016-1326-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]},"article-number":"139"}}